PubRank

J Boultwood

Author PubWeight™ 31.61‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts. N Engl J Med 2011 7.89
2 A novel gene, NSD1, is fused to NUP98 in the t(5;11)(q35;p15.5) in de novo childhood acute myeloid leukemia. Blood 2001 2.50
3 Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells. Leukemia 2010 2.30
4 Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia. Leukemia 2010 2.23
5 Gene expression profiling in MDS and AML: potential and future avenues. Leukemia 2011 1.38
6 MicroRNA expression in lymphocyte development and malignancy. Leukemia 2008 1.30
7 The 5q- syndrome. Hematology 2004 1.23
8 Combined immunophenotyping and FISH identifies the involvement of B-cells in 5q- syndrome. Genes Chromosomes Cancer 2000 0.94
9 Molecular cytogenetic delineation of the critical deleted region in the 5q- syndrome. Genes Chromosomes Cancer 1998 0.92
10 Effects of L-leucine in 5q- syndrome and other RPS14-deficient erythroblasts. Leukemia 2012 0.90
11 Molecular characterization of the 7q deletion in myeloid disorders. Br J Haematol 1996 0.89
12 The human POP2 gene: identification, sequencing, and mapping to the critical region of the 5q- syndrome. Genomics 1999 0.87
13 hTERT, the catalytic component of telomerase, is downregulated in the haematopoietic stem cells of patients with chronic myeloid leukaemia. Leukemia 2006 0.83
14 Detection of NPM-ALK DNA rearrangement in CD30 positive anaplastic large cell lymphoma. Br J Haematol 1995 0.79
15 Expression profiling of persistent polyclonal B-cell lymphocytosis suggests constitutive expression of the AP-1 transcription complex and downregulation of Fas-apoptotic and TGFbeta signalling pathways. Leukemia 2008 0.78
16 A new recurrent translocation, t(5;11)(q35;p15.5), associated with del(5q) in childhood acute myeloid leukemia. The UK Cancer Cytogenetics Group (UKCCG) Blood 1999 0.78
17 Activation of the mTOR signaling pathway by L-leucine in 5q- syndrome and other RPS14-deficient erythroblasts. Leukemia 2013 0.77
18 Clonality of cell populations in refractory anaemia using combined approach of gene loss and X-linked restriction fragment length polymorphism-methylation analyses. Br J Haematol 1991 0.77
19 Disruption of SF3B1 results in deregulated expression and splicing of key genes and pathways in myelodysplastic syndrome hematopoietic stem and progenitor cells. Leukemia 2015 0.76
20 Mutation analysis of the SPARC gene in the 5q-syndrome. Am J Hematol 2000 0.76
21 Interleukin-1 beta gene deregulation associated with chromosomal rearrangement: a candidate initiating event for murine radiation-myeloid leukemogenesis? Mol Carcinog 1989 0.75
22 Glutathione S-transferase gene deletions in myelodysplasia. Lancet 1997 0.75
23 NPM-ALK gene fusion and Hodgkin's disease. Blood 1997 0.75
24 Myelodysplastic disorders with hemizygous M-CSF receptor gene loss do not show point mutations of codon 969 within the remaining allele. Leukemia 1993 0.75
25 BRCA2 gene deletion is rare in chronic lymphocytic leukemia. Am J Hematol 1998 0.75
26 Practical considerations in the analysis of chromosomal deletion breakpoints by pulsed field gel electrophoresis. Br J Haematol 1991 0.75
27 Radiation-induced chromosome 2 rearrangement and initiation of murine acute myeloid leukemia. Radiat Res 1990 0.75
28 Isolation of cDNAs using the YAC hybridization screen method. Methods Mol Biol 1997 0.75
29 Hematological features of patients with myelodysplastic syndromes associated with a chromosome 5q deletion. Am J Hematol 1995 0.75